Clinical trials: FECD3
Fuchs Endothelial Corneal Dystrophy, FECD3
Study With QR-504a to Evaluate Safety, Tolerability & Corneal Endothelium Molecular Biomarker(s) in Subjects With FECD3
PQ-504a-001 (Fuchs Focus) is an open-label, single-dose, exploratory study to evaluate safety, tolerability, and corneal endothelium molecular biomarker(s) in subjects with Fuchs Endothelial Corneal Dystrophy with Trinucleotide…
- Conditions
- Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases, LRS
- Trial name
- Fuchs Focus (NCT05052554)
- Testing
- QR-504a
- Where
- United Kingdom
- Sponsor
- ProQR Therapeutics